SUPPLEMENTAL FINANCIAL INFORMATION | ||||||||||||||||
STOCK-BASED COMPENSATION EXPENSE | ||||||||||||||||
(Unaudited, in thousands) | ||||||||||||||||
Three Months Ended
September 30, |
Nine Months Ended
September 30, | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Cost of revenue | $ | 453 | $ | 403 | $ | 1,264 | $ | 1,217 | ||||||||
Research and development | 3,838 | 3,986 | 11,297 | 11,001 | ||||||||||||
Selling, general and administrative | 9,678 | 9,127 | 28,198 | 22,023 | ||||||||||||
Total stock-based compensation expense | $ | 13,969 | $ | 13,516 | $ | 40,759 | $ | 34,241 |
RECONCILIATION OF NET INCOME TO NON-GAAP NET INCOME | ||||||||||||||||
(Unaudited, in thousands, except per share amounts) | ||||||||||||||||
Three Months Ended
September 30, |
Nine Months Ended
September 30, | |||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Net income | $ | 23,642 | $ | 14,373 | $ | 53,132 | $ | 36,146 | ||||||||
Net income as a percentage of revenue | 18.3 | % | 13.5 | % | 15.6 | % | 12.7 | % | ||||||||
Adjustments to reconcile net income to non-GAAP net income: | ||||||||||||||||
Stock-based compensation expense | 13,969 | 13,516 | 40,759 | 34,241 | ||||||||||||
Amortization of acquisition-related intangible assets | 513 | 513 | 1,538 | 1,538 | ||||||||||||
Deferred compensation plan expense (income) | (50 | ) | (70 | ) | 90 | (218 | ) | |||||||||
Tax effect | (1,519 | ) | (823 | ) | (4,285 | ) | (2,901 | ) | ||||||||
Non-GAAP net income | $ | 36,555 | $ | 27,509 | $ | 91,234 | $ | 68,806 | ||||||||
Non-GAAP net income as a percentage of revenue | 28.4 | % | 25.8 | % | 26.7 | % | 24.1 | % | ||||||||
Non-GAAP net income per share: | ||||||||||||||||
Basic | $ | 0.88 | $ | 0.68 | $ | 2.21 | $ | 1.71 | ||||||||
Diluted | $ | 0.84 | $ | 0.66 | $ | 2.10 | $ | 1.65 | ||||||||
Shares used in the calculation of non-GAAP net income per share: | ||||||||||||||||
Basic | 41,458 | 40,590 | 41,276 | 40,335 | ||||||||||||
Diluted | 43,486 | 41,895 | 43,384 | 41,752 |